Effect of Ruji formula combined with shuowang moxibustion on postoperative immune function and circulating tumor cells (DNA) in patients with TNBC

Foshan hospital of traditional Chinese medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients who met the diagnostic criteria of triple negative breast cancer;
•2. After standardized treatment in accordance with the guidelines and specifications for breast cancer diagnosis and treatment of China Anti Cancer Association (2015 Edition), the patients with triple negative breast cancer in stage 0-III were in a tumor free state;
•3. Aged from 18 to 70 years;
•4. ECOG score: 0-1;
•5. The expected survival time was more than 9 months;
•6. Informed consent to participate in this study, signed informed consent, expected good compliance, follow-up.

•1. Patients with other malignant tumors or immune system diseases (such as AIDS, rheumatism, severe infection, etc.);
•2. Previously found to be allergic to drugs contained in Ruji formula and shuowang moxibustion ointment;
•3. The skin condition is poor, unable to accept the treatment of shuowang moxibustion;
•4. Pregnant women
•5. Patients with bone marrow, liver, kidney, heart, lung and immune dysfunction;
•6. 3 months before the detection of immune function received treatment that may affect immune function;
•7. Other clinical trials were conducted at the same time.

发起方

Foshan hospital of traditional Chinese medicine